efficacy of p53 gene therapy depends on
the p53 status of gliomas. U87 human glioma cells (wild-type p53) were
highly resistant to adenoviral p53-mediated apoptosis, whereas glioma cells with mutated p53 cells underwent extensive apoptosis
